Yakup ALSANCAK, Ahmet Seyfeddin GÜRBÜZ, Abdullah İÇLİ, Ahmet Lütfü SERTDEMİR, Hasan KAN, Muhammed Fatih KALELİ, Mustafa DURAN

Enfektif Endokarditli Hastalar: Üçüncü Basamak Tek Merkez Sevk HastanesininBeş Yıllık Deneyimi

Amaç: Enfektif endokardit (EE), kalbin iç yüzeyinden kaynaklanan sistemik bir enfeksiyondur. Hastalığın nadir olması ve büyük randomize klinik çalışmalardan veri bulunmaması nedeniyle, EE'nin önlenmesi, teşhisi ve tedavisi için öneriler hala uzman görüşlerinden ve gözlemsel kohort çalışmalarından elde edilmektedir. Bu çalışmada Türkiye'deki tek bir üçüncü basamak hastanesinde EE'nin epidemiyolojik ve klinik özelliklerini tanımlamayı amaçladık.Materyal ve Metot: Kardiyoloji kliniğimize EE nedeniyle başvuran 61 (≥18 yaş) hastanın kayıtları geriye dönük olarak incelendi. Hastaların klinik ve demografik özellikleri, laboratuvar değerleri, mikrobiyolojik bulgular, tedavi yöntemleri, transtorasik ekokardiyografi (TTE) kayıtları ve transözofageal ekokardiyografi (TÖE) tetkikleri ve hastanede yatış sonuçları değerlendirildi.Bulgular: Verilerimize göre EE'den ölen hastalarda, hayatta kalanlara göre serum beyaz kan hücresi (WBC), sedimantasyon (ESR), C reaktif protein (CRP) ve prokalsitonin düzeyleri anlamlı olarak yüksekti (p

Patients with Infective Endocarditis: Experience of a Single-Center and Tertiary ReferralHospital for Five-Years

Objective: Infective endocarditis (IE) is a systemic infection which results from the inner surface of the heart. Due to rarity of disease and absence of data from large randomized clinical trials, recommendations for prevention, diagnosis and treatment of IE are still derived from expert opinion and observational cohort studies. In this study to we aimed to describe the epidemiological and clinical features of IE in a single tertiary-care hospital in Turkey.Materials and Methods: The records of 61 patients aged ≥18 who were admitted to our cardiology clinic due to IE were investigated retrospectively. Clinical and demographic characteristics of patients, labratory values, microbiological findings, treatment modalities, records of transthoracic echocardiography (TTE), and transesophageal echocardiography (TEE) examinations and hospitalization outcomes were evaluated.Results: According to our data, serum white blood cell (WBC), sedimantation (ESR), C reactive protein (CRP) and procalcitonin levels were significantly higher in patients who died from IE compared to those who survived (p

PDF

___

1. Kucukates E, Gultekin N, Bagdatli Y. Cases of active infective endocarditis in a university hospital during a 10-year period. J Pak Med Assoc. 2013;63(9):1163-1167.
2. Khan NU, Farman MT, Sial J. A, Achakzai AS, Saghir T, Ishaq M. Changing trends of infective endocarditis. J Pak Med Assoc. 2010;60(1);24-27.
3. Beynon RP, Bahl VK, Prendergast BD. Infective endocarditis. BMJ. 2006;333:334-339. doi:10.1136/bmj.333.7563.334
4. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162 (1):90-4. doi:10.1001/archinte.162.1.90
5. Nunes MC, Gelape CL, Ferrari TC. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis. 2010;14(5):e394-8. doi:10.1016/j.ijid.2009.06.024
6. Elbey MA, Akdağ S, Kalkan ME, et al. A multicenter study on experience of 13 tertiary hospitals in Turkey in patients with infective endocarditis. Anatol J Cardiol. 2013;13(6):523-7. doi:10.5152/ akd.2013.172
7. Crawford MH, Durack DT. Clinical presentation of infective endocarditis. Cardiol Clin. 2003;21 (2):159-166. doi:10.1016/s0733-8651(03)00023-7
8. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The task force for the management of ınfective endocarditis of the european society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;36(44):3075-3128. doi:10.1093/eurheartj/ehv319
9. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96(3):200-9. doi:10.1016/0002-9343(94)90143-0
10.Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15(2):167-84. doi:10.1067/ mje.2002.120202
11.Dąbek J, Majewski M, Michalak-Kolarz M, Gąsior Z. Patients with infective endocarditis: Five-year observation from a single reference center. Adv Clin Exp Med. 2017;26(8):1197- 1205. doi: 10.17219/acem/64874
12.Vincent LL, Otto CM. Infective Endocarditis: Update on Epidemiology, Outcomes, and Management. Curr Cardiol Rep. 2018;20(10):86. doi:10.1007/s11886-018-1043-2
13.Delahaye F, De Gevigney G. Endocardites infectieuses : Formes particulières (coeur droit, prothèse valvulaire, dispositif électronique intracardiaque) [Infective endocarditis and specific situations: Right heart, valve prosthesis, cardiac implantable electronic device]. Presse Med (French). 2019;48(5):549-555. doi:10.1016/ j.lpm.2019.04.006
14.Hubers SA, DeSimone DC, Gersh BJ, Anavekar NS. Infective Endocarditis: A Contemporary Review. Mayo Clin Proc. 2020;95(5):982-997. doi:10.1016/j.mayocp.2019.12.008
15.Iung B. Endocardite infectieuse. Épidémiologie, physiopathologie et anatomopathologie [Infective endocarditis. Epidemiology, pathophysiology and histopathology]. Presse Med (French). 2019;48 (5):513-521. doi:10.1016/j.lpm.2019.04.009.
16.Menchi-Elanzi M, Ramos-Rincón JM, MerinoLucas E, et al. Infective endocarditis in elderly and very elderly patients. Aging Clin Exp Res. 2020;32(7):1383-1388. doi:10.1007/s40520-019- 01314-3
17.Slipczuk L, Codolosa JN, Davila CD, et al. Infective endocarditis epidemiology over five decades: A systematic review. PLoS One. 2013;8 (12):e82665. doi:10.1371/journal.pone.0082665
18.Damasco PV, Correal JCD, Cruz-Campos ACD, et al. Epidemiological and clinical profile of infective endocarditis at a Brazilian tertiary care center: an eight-year prospective study. Rev Soc Bras Med Trop. 2019;52:e2018375. doi:10.1590/0037-8682-0375-2018
19.Delahaye F, Alla F, Beguinot I, et al. In-hospital mortality of infective endocarditis: Prognostic factors and evolution over an 8-year period. Scand J Infect Dis. 2007;39(10):849-857. doi:10.1080/00365540701393088
20.Rajani R, Klein JL. Infective endocarditis: A contemporary update. Clin Med (Lond). 2020;20 (1):31-35. doi:10.7861/clinmed.cme.20.1.1
21.Hase R, Otsuka Y, Yoshida K, Hosokawa N. Profile of infective endocarditis at a tertiary-care hospital in Japan over a 14-year period: characteristics, outcome and predictors for in-hospital mortality. Int J Infect Dis. 2015;33:62-6. doi:10.1016/j.ijid.2015.01.003
22.Diab D, Haziza F, Russel S, et al. Endocardites infectieuses opérées : indications chirurgicales, complications, mortalité intrahospitalière et à long terme [Surgical treatment of infective endocarditis: Surgical indications, complications, intrahospital and long-term mortality]. Ann Cardiol Angeiol (Paris). 2020;69(6):385-391. doi:10.1016/j.ancard.2020.09.037